The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to research published ...
Dec 9, 2022
0
2
Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
Brief exposure to direct-to-consumer advertising (DTCA) has a large and positive association with medication-related demand intentions, according to a study published online Aug. 12 in JAMA Health Forum.
Aug 12, 2022
0
3
Laparoscopic surgery is noninferior to open gastrectomy for locally advanced gastric cancer (AGC) at five years, according to a study published online July 20 in JAMA Surgery.
Aug 1, 2022
0
14
For patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port delivery system (PDS) with one refill costs more than intravitreal ranibizumab or aflibercept injections if about 11 or 10 injections, ...
Jun 23, 2022
0
2
Drug-coated devices (DCDs) are not associated with increased long-term mortality among older patients who undergo femoropopliteal artery revascularization, according to a research letter published online May 20 in Circulation: ...
Jun 1, 2022
0
3
Most patients have positive views about the ability of artificial intelligence (AI) to improve care but have concerns about unintended consequences, according to a research letter published online May 4 in JAMA Network Open.
May 13, 2022
0
2
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19, according to a study published online ...
May 5, 2022
0
63
Among patients with Lennox-Gastaut syndrome (LGS), the percentage reduction in the frequency of drop seizures is greater with fenfluramine versus placebo, according to a study published online May 2 in JAMA Neurology.
May 2, 2022
0
14
The incidence of Guillain-Barré syndrome (GBS) is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination, according to a study published online April 26 in JAMA Network Open.
Apr 27, 2022
0
60
